Shares of CVS Health Corp tumbled on Friday with other drugstore chains following a report that it could acquire insurer Aetna Inc to fortify itself against a possible Amazon Inc entry into the sector.
CVS Health has offered to buy Aetna for more than US$200 per share, the Wall Street Journal reported late on Thursday, citing people familiar with the matter.
The newspaper described the talks as serious, but said they might not lead to a deal.
Shares of CVS Health lost 5.9 percent, while Aetna dropped 3.9 percent.
A merger of CVS and Aetna would create a healthcare behemoth and put huge pressure on standalone players such as Express Scripts Holding Co and Walgreens Boots Alliance Inc. Express Scripts would become the last major standalone pharmacy-benefit manager (PBM) not allied with a major insurer.
Under a combined roof, the insurance arm of CVS-Aetna could help keep costs down by routing patients needing basic urgent care to CVS-owned walk-in clinics and keeping them out of expensive hospital emergency rooms, Mizuho Securities Co analyst Ann Hynes said in a note to clients.
The company would also become a formidable competitor to UnitedHealth Group Inc, the biggest health insurer and owner of its own PBM unit, OptumRx.
CVS and Aetna declined to comment.
The possible deal comes amid signs that Amazon.com Inc is preparing to expand into pharmacy distribution.
A report in the St Louis Post-Dispatch said Amazon, which has disrupted the grocery business with its US$13.7 billion acquisition of Whole Foods Market Inc, had obtained licenses in 12 states to become a wholesale pharmaceutical distributor.
“While these licenses do not seemingly permit [Amazon] to act as a dispensing pharmacy, it does allow it to deliver relevant pharmaceutical and medical products to pharmacies,” Credit Suisse Group AG said in a note.
“We can only speculate as to what Amazon’s next steps may be,” the note added. “While we acknowledge the inherent challenges and complexities of the supply chain, the specter of Amazon continues to weigh on sentiment across our universe of distributors, pharmacies, and [pharmacy benefit managers].”
CFRA Research analyst Joe Agnese said Amazon’s move was the “big threat for the sector right now.”
Additional reporting by Bloomberg
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained